A Passion for Value-Based Innovations in Medicine

XPOMET© Medicinale 10 - 12 October 2019, Berlin, Germany.
International leaders in medicine aim at analyzing, evaluating, and incorporating the major developments in the field into the ecosystem of XPOMET Medicinale. These leaders forming the Medical Board met on 20 March to discuss the trending topics and how to approach them regarding the structure and goals of the Festival.

Christian Dierks, owner of the innovation consultancy for healthcare and life sciences Dierks + Company, hosted the meeting at the Helix Hub in Berlin. In addition to key members of the Board, XPOMET co-founder Alois Steidel and, via video link, XPOMET founder Ulrich Pieper were present as well as Simon Richter, Head of Exhibitions.

Creating a path towards a successful XPOMET was the goal of this meeting. Organizers expect to welcome 5,000 attendees for the Festival in Berlin. Marrying the right topics with the right structures will be the major success factor in making this happen. At that meeting, communicating the "passion of value-based innovations in Medicine" was considered a pillar of this approach. It will include social innovations, the penetration of digitization, and with it the urge from the public to see healthcare catch up with the rest of society in terms of technological progress towards digital health. With the expertise contributed by each member in the group, the board represents a wealth of knowledge that can help to accelerate the transformation process in Germany and Europe. Medical Board head Dr. Henri Michael von Blanquet anchored the "Open agenda for the definition of targets", a platform to discuss how a resilient networking structure can be created which ensures that XPOMET brings in the right voices to amplify its core message. XPOMET aims for 150 key evangelists across its medical board, ambassadors, and advisory board. This follows "Dunbar's number", defined as the "suggested cognitive limit to the number of people with whom one can maintain stable social relationships... relationships in which an individual knows who each person is and how each person relates to every other person". Healthcare, according to the discussion, needs this kind of leadership in order to help structures move to the tipping point.

As part of this strategy, XPOMET's aim is to go global and build an international medical board with commitment from all fields. It will pool resources to strengthen its impact on the way we provide care in the future.

"At some point in my career I started to understand that better health requires more than my diagnosis as a physician," explained Prof. Dr. med. Bettina Borisch, MPH, Head, Institute of Global Health, University of Geneva, as well as Director and Head of the World Federation of Public Health Associations. "That's why I moved into Public Health; this allows me to make a contribution to people leading healthier lives. My commitment for XPOMET comes from the idea that bringing together the knowledge of stakeholders from multiple backgrounds will help to accelerate progress in health. I myself am bringing in biomedical know-how and the global health perspective... We need to evaluate emerging technologies and define how to employ them for the benefit of citizens worldwide."

"Digitization and Big Data analytics are happening today," outlined Prof. Dr. Harald Schmidt, MD, PhD, PharmD, FESC, Professor and Head of the Department of Pharmacology & Personalized Medicine Faculty of Health, Medicine & Life Sciences, Maastricht University. "Discussions on these developments involve all relevant disciplines. I see my contribution, as a medical doctor and a pharmacist, in particular in providing proofs of concepts - they will provide evidence that this is the next big thing. The question I ask myself is, will Europe lead, co-lead, or follow? One thing is for sure: XPOMET will foster this progress, and I am glad to have a part in it."

For further information, please visit:
https://xpomet.com

About XPOMET© Medicinale

XPOMET© Medicinale is an international festival platform to showcase best practice and highlight trends in global healthcare and forecast future developments in health and tech. Creative disruption and knowledge transfer are the backbone of Medicinale. Over 5,000 international guests will hear from over 150 inspiring speakers, engage in public and private deep dives, and join more than 200 of the most inventive companies with the aim of enabling and fostering new transdisciplinary solutions, business models, and partnerships in medicine and life sciences.

Most Popular Now

Integrating Care Records is Good. Using …

Opinion Article by Dr Paul Deffley, Chief Medical Officer, Alcidion. A single patient record already exists in the NHS. Or at least, that’s a perception shared by many. A survey of...

Should AI Chatbots Replace Your Therapis…

The new study exposes the dangerous flaws in using artificial intelligence (AI) chatbots for mental health support. For the first time, the researchers evaluated these AI systems against clinical standards...

AI could Help Pathologists Match Cancer …

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and collaborators, suggests that artificial intelligence (AI) could significantly improve how...

AI Detects Early Signs of Osteoporosis f…

Investigators have developed an artificial intelligence-assisted diagnostic system that can estimate bone mineral density in both the lumbar spine and the femur of the upper leg, based on X-ray images...

AI Model Converts Hospital Records into …

UCLA researchers have developed an AI system that turns fragmented electronic health records (EHR) normally in tables into readable narratives, allowing artificial intelligence to make sense of complex patient histories...

AI Sharpens Pathologists' Interpret…

Pathologists' examinations of tissue samples from skin cancer tumours improved when they were assisted by an AI tool. The assessments became more consistent and patients' prognoses were described more accurately...

AI Tool Detects Surgical Site Infections…

A team of Mayo Clinic researchers has developed an artificial intelligence (AI) system that can detect surgical site infections (SSIs) with high accuracy from patient-submitted postoperative wound photos, potentially transforming...

Forging a Novel Therapeutic Path for Pat…

Rett syndrome is a devastating rare genetic childhood disorder primarily affecting girls. Merely 1 out of 10,000 girls are born with it and much fewer boys. It is caused by...

Mayo Clinic's AI Tool Identifies 9 …

Mayo Clinic researchers have developed a new artificial intelligence (AI) tool that helps clinicians identify brain activity patterns linked to nine types of dementia, including Alzheimer's disease, using a single...

Meet Your Digital Twin

Before an important meeting or when a big decision needs to be made, we often mentally run through various scenarios before settling on the best course of action. But when...

NHS National Rehabilitation Centre to De…

The new NHS National Rehabilitation Centre will deploy technology to help patients to maintain their independence as they recover from life-changing injuries and illnesses and regain quality of life. Airwave Healthcare...

AI Finds Hundreds of Potential Antibioti…

Snake, scorpion, and spider venom are most frequently associated with poisonous bites, but with the help of artificial intelligence, they might be able to help fight antibiotic resistance, which contributes...